HighTower Advisors Portfolio holdings
AUM
$79.8B
1-Year Return
17.44%
This Quarter Return
+8.61%
1 Year Return
+17.44%
3 Year Return
+65.6%
5 Year Return
+120.67%
10 Year Return
+243.37%
AUM
$79.8B
AUM Growth
+$6.15B
(+8.3%)
Cap. Flow
+$1.38B
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
3,757
New
261
Increased
1,550
Reduced
1,602
Closed
168
Top Buys
| 1 |
Preformed Line Products
PLPC
|
$113M |
| 2 |
WisdomTree US Quality Growth Fund
QGRW
|
$107M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
$96.7M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$79.7M |
| 5 |
Meta Platforms (Facebook)
META
|
$76.9M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$48.6M |
| 2 |
Broadcom
AVGO
|
$46.9M |
| 3 |
Clorox
CLX
|
$44.7M |
| 4 |
Visa
V
|
$44.5M |
| 5 |
GMO US Quality ETF
QLTY
|
$43.7M |
Sector Composition
| 1 | Technology | 13.55% |
| 2 | Financials | 10.32% |
| 3 | Consumer Discretionary | 5.93% |
| 4 | Industrials | 5.06% |
| 5 | Healthcare | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Fate Therapeutics
FATE
$116M
| $41.7K | ﹤0.01% |
37,200
+27,000
| +265% | +$30.2K |
|
3502
VistaGen Therapeutics
VTGN
$109M
| $41.7K | ﹤0.01% |
20,828
| – | – |
|
3503
Prospect Capital
PSEC
$1.34B
| $41.3K | ﹤0.01% |
12,980
+442
| +4% | +$1.41K |
|
3504
Solid Power
SLDP
$760M
| $41.2K | ﹤0.01% |
+18,829
| New | +$41.2K |
|
3505
Acco Brands
ACCO
$364M
| $39.8K | ﹤0.01% |
11,127
-84,062
| -88% | -$301K |
|
3506
SmartRent
SMRT
$275M
| $39.4K | ﹤0.01% |
39,840
| – | – |
|
|
LAR
3507
Lithium Argentina AG
LAR
$573M
| $38.9K | ﹤0.01% |
18,707
-200
| -1% | -$416 |
|
3508
OmniAb
OABI
$246M
| $37.2K | ﹤0.01% |
21,382
-500
| -2% | -$870 |
|
|
NB
3509
NioCorp Developments
NB
$310M
| $37.1K | ﹤0.01% |
15,925
+1,755
| +12% | +$4.09K |
|
|
BHR
3510
Braemar Hotels & Resorts
BHR
$203M
| $36.8K | ﹤0.01% |
15,006
+5,000
| +50% | +$12.3K |
|
3511
Tilray
TLRY
$1.31B
| $36.6K | ﹤0.01% |
88,266
-4,094
| -4% | -$1.7K |
|
|
SVC
3512
Service Properties Trust
SVC
$481M
| $36.5K | ﹤0.01% |
15,276
-105,947
| -87% | -$253K |
|
|
MIN
3513
MFS Intermediate Income Trust
MIN
$307M
| $36K | ﹤0.01% |
13,300
| – | – |
|
3514
Relay Therapeutics
RLAY
$710M
| $35.7K | ﹤0.01% |
10,320
-236,856
| -96% | -$820K |
|
|
HKD
3515
AMTD Digital
HKD
$503M
| $35.5K | ﹤0.01% |
+20,260
| New | +$35.5K |
|
3516
Opendoor
OPEN
$4.89B
| $35.1K | ﹤0.01% |
65,937
-44,087
| -40% | -$23.5K |
|
|
BRNS
3517
Barinthus Biotherapeutics
BRNS
$50.5M
| $34.8K | ﹤0.01% |
37,450
| – | – |
|
3518
TELA Bio
TELA
$63M
| $31.7K | ﹤0.01% |
16,352
+6,000
| +58% | +$11.6K |
|
|
CMPS
3519
Compass Pathways
CMPS
$493M
| $31.5K | ﹤0.01% |
11,242
+485
| +5% | +$1.36K |
|
|
CRON
3520
Cronos Group
CRON
$957M
| $30.3K | ﹤0.01% |
15,851
-46
| -0.3% | -$88 |
|
3521
Lisata Therapeutics
LSTA
$18.7M
| $29.1K | ﹤0.01% |
10,042
| – | – |
|
3522
Vanda Pharmaceuticals
VNDA
$272M
| $28.2K | ﹤0.01% |
5,981
-505
| -8% | -$2.38K |
|
3523
Humacyte
HUMA
$226M
| $27.7K | ﹤0.01% |
13,253
+2,500
| +23% | +$5.23K |
|
3524
iQIYI
IQ
$2.61B
| $27.7K | ﹤0.01% |
15,639
| – | – |
|
3525
Calidi Biotherapeutics
CLDI
$8.56M
| $27.5K | ﹤0.01% |
9,956
| – | – |
|